Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study

SUMMARY: This study aimed to determine the interaction between baseline FRAX(®) fracture probability and romosozumab efficacy. Using an ITT approach, it was determined that the efficacy of romosozumab on clinical fracture, osteoporotic fracture, and major osteoporotic fracture is significantly great...

Descripción completa

Detalles Bibliográficos
Autores principales: McCloskey, E. V., Johansson, H., Harvey, N. C., Lorentzon, M., Shi, Y., Kanis, J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376732/
https://www.ncbi.nlm.nih.gov/pubmed/33537844
http://dx.doi.org/10.1007/s00198-020-05815-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376732/
https://www.ncbi.nlm.nih.gov/pubmed/33537844
http://dx.doi.org/10.1007/s00198-020-05815-0

Ejemplares similares